News

Telephonic and personalized diabetes self-education programs which fit into patient’s busy lives will make a greater impact than in-person classes only.

In this Q&A, a physician and lymphoma expert discusses treatment advances and promising signs for the future.

Will President-elect Donald Trump affect the outcome of the Anthem-Cigna and Aetna-Humana mergers?

An ASH presenter describes how better health IT and better institutional practices are necessary to leverage EHRs for quality of care.

Novel immunotherapy treatments are showing promise for patients with acute lymphoblastic leukemia (ALL), but they can trigger cytokine release syndrome.

Immune checkpoint inhibitors are taking the stage in treating relapsed and refractory Hodgkin lymphoma. Read more.

Joint ventures are gaining steam as health plans and providers look for new ways to work together.

Two new major studies on a biosimilar to trastuzumab (Herceptin, Genentech) to treat HER2-positive metastatic breast cancer and HER2-positive gastric cancer demonstrated equivalency.

Two experts discuss top-of-mind women’s healthcare issues in managed care.

Does your analytics team have what it takes? Experts share their top recommendations.

From “all-in-one” healthcare appointments to coordinating women’s care for convenience, here’s how providers and researchers say plans and providers can prioritize

The AMA and medical schools across the country are placing new emphasis on population health management and value-based care.

Experts share how Trump could change Obamacare coverage, accessibility, affordability, Medicare/Medicaid, price transparency, and more.

Here’s how one non-profit health plan harnessed the power of medical and pharmacy data to rein in drug costs.

Two new diabetes drugs, both long-acting injectable insulin products, were simultaneously approved by FDA.

Leader of the YMCA’s Diabetes Prevention Program explains how it is improving diabetes care.

The Independence Blue Cross Foundation Healthy Hearts Initiative aims to improve survival rates for sudden cardiac arrest, increase CPR preparedness.

As fee-for-service rapidly transforms into value-based care, the industry must improve member engagement and outcomes by using targeted care management interventions that help deliver bottom-line results across a broader spectrum of the population.

The path to bundled payment success can be daunting. Here’s three universal concepts that will promote success under the various CMS models.

Rise in use of outpatient care and professional services contributed to quicker growth in spending for the privately insured over previous years.

Retail clinics emerge as a way to satisfy the growing demand for healthcare created by the newly insured under the ACA, but contrary to expectations, they do not appear to be leading to meaningful reductions in low-acuity ED visits.

Understand Medicare Part D’s design and its coverage gap to offer the most affordable prescription drug options for patients.

Following the GOP’s success on Election Day, the nation is quickly tuning in to what this all means for healthcare coverage.

CMS announced changes to how Medicare pays for primary care. Here’s 5 things to consider.

: Remembering to engage in healthy behavior can often slip to the bottom of our list of priorities. In a world where we need to be reminded and motivated to be the healthiest version of ourselves, the right nudges at the right time can help us get there.

A global phase 3 study of erenumab (Amgen and Novartis) showed that the drug was able to prevent migraines headaches.

After a successful phase 3 study, a breakthrough therapy to treat multi-drug resistant (MDR) HIV-1 is expected to launch in the United States in 2017.

Humana’s value-based reimbursement model with physicians has helped to improve care quality and health outcomes for its Medicare Advantage (MA) program members.

Here’s a three-pronged approach to improve adherence program efficiency that leverages predictive data analytics, hospital on-site pharmacies and post discharge follow-up evaluation to achieve real, measurable results.

This year’s American Society of Hematology (ASH) Conference, held in San Diego, will feature a wide array of sessions.